24
Participants
Start Date
September 30, 2013
Primary Completion Date
March 31, 2016
Study Completion Date
January 31, 2017
Transplantation of lungs obtained from Non-Heart-Beating Donors (NHBDs) after ex-vivo perfusion w/ STEEN Solution™
After EVLP, lungs will be cooled in the circuit to room temperature, then flushed with cold Perfadex™, and taken to UNCH where they will have an ex-vivo CT scan. Lungs determined suitable will be offered to consented patients at UNC Hospitals and Duke University Medical Center based on Lung Allocation Score. Lungs not considered for transplantation may be subjected to different experiments but are not to be a part of this research study. In summary, lungs with good and stable function during EVLP will be transplanted into recipients as per current clinical practice.
STEEN Solution™
This solution is a buffered dextran and albumin-containing extracellular perfusate with an optimal colloid osmotic pressure developed specifically for extra-corporeal perfusion of lungs.
UNC-Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
Collaborators (1)
Duke University
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Vitrolife
INDUSTRY
XVIVO Perfusion
INDUSTRY
University of North Carolina, Chapel Hill
OTHER